BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 119038)

  • 1. Adenine arabinoside inhibition of adenovirus replication enhanced by an adenosine deaminase inhibitor.
    Wigand R
    J Med Virol; 1979; 4(1):59-65. PubMed ID: 119038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of the biological activity of cordycepin (3'-deoxyadenosine) by the adenosine deaminase inhibitor 2'-deoxycoformycin.
    Johns DG; Adamson RH
    Biochem Pharmacol; 1976 Jun; 25(12):1441-4. PubMed ID: 1084747
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiviral activity of an adenosine deaminase inhibitor: decreased replication of herpes simplex virus.
    Williams BB; Lerner AM
    J Infect Dis; 1975 Jun; 131(6):673-7. PubMed ID: 166117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificity of adenosine deaminase inhibitors.
    Henderson JF; Brox L; Zombor G; Hunting D; Lomax CA
    Biochem Pharmacol; 1977 Nov; 26(21):1967-72. PubMed ID: 562667
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of a new adenosine deaminase inhibitor, isocoformycin, on toxicity, antitumor activity and tissue distribution of formycin A and 9-beta-D-arabinofuranosyladenine.
    Hidaka T; Katayama K; Yamashita K; Yamashita T; Watanabe K; Shimazaki M; Ohno M; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1980 Mar; 33(3):303-9. PubMed ID: 7380742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a novel adenosine deaminase inhibitor (co-vidarabine, co-V) upon the antiviral activity in vitro and in vivo of vidarabine (Vira-Atm) for DNA virus replication.
    Sloan BJ; Kielty JK; Miller FA
    Ann N Y Acad Sci; 1977 Mar; 284():60-80. PubMed ID: 212990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of adenosine deaminase by co-vidarabine and its effect on the metabolic disposition of adenine arabinoside (vidarabine).
    Borondy PE; Chang T; Maschewske E; Glazko AJ
    Ann N Y Acad Sci; 1977 Mar; 284():9-20. PubMed ID: 280160
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiviral activity in the rabbit cornea of adenine arabinoside, Ara-A 5' monophosphate, and hypoxanthine arabinoside; and interactions with adenosine deaminase inhibitor.
    Falcon MG; Jones BR
    J Gen Virol; 1977 Jul; 36(1):199-202. PubMed ID: 196039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythro-9-(2-hydroxy-3-nonyl)adenine as a specific inhibitor of herpes simplex virus replication in the presence and absence of adenosine analogues.
    North TW; Cohen SS
    Proc Natl Acad Sci U S A; 1978 Oct; 75(10):4684-8. PubMed ID: 216993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of cytotoxicity and antitumor activity of adenosine analogs by the adenosine deaminase inhibitor adecypenol.
    Tanaka H; Kawakami T; Yang ZB; Komiyama K; Omura S
    J Antibiot (Tokyo); 1989 Nov; 42(11):1722-4. PubMed ID: 2584153
    [No Abstract]   [Full Text] [Related]  

  • 11. Increased toxicity of 9-beta-D-arabinofuranosyladenine in the presence of an inhibitor of adenosine deaminase.
    Plunkett W; Cohen SS
    Ann N Y Acad Sci; 1977 Mar; 284():91-102. PubMed ID: 280161
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of adenosine deaminase to increase the antitumor activity of adenine nucleoside analogues.
    Plunkett W
    Ann N Y Acad Sci; 1985; 451():150-9. PubMed ID: 3907452
    [No Abstract]   [Full Text] [Related]  

  • 13. Toxicities of adenosine and 2'-deoxyadrenosine in L cells treated with inhibitors of adenosine deaminase.
    Lapi L; Cohen SS
    Biochem Pharmacol; 1977 Jan; 26(1):71-6. PubMed ID: 299815
    [No Abstract]   [Full Text] [Related]  

  • 14. Adechlorin, a new adenosine deaminase inhibitor containing chlorine production, isolation and properties.
    Omura S; Imamura N; Kuga H; Ishikawa H; Yamazaki Y; Okano K; Kimura K; Takahashi Y; Tanaka H
    J Antibiot (Tokyo); 1985 Aug; 38(8):1008-15. PubMed ID: 3840153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine deaminase inhibitors. Synthesis and biological activity of deaza analogues of erythro-9-(2-hydroxy-3-nonyl)adenine.
    Cristalli G; Franchetti P; Grifantini M; Vittori S; Lupidi G; Riva F; Bordoni T; Geroni C; Verini MA
    J Med Chem; 1988 Feb; 31(2):390-3. PubMed ID: 3339608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of the biological activity of adenosine analogs by the adenosine deaminase inhibitor 2'-deoxycoformycin.
    Adamson RH; Zaharevitz DW; Johns DG
    Pharmacology; 1977; 15(1):84-9. PubMed ID: 840892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Action of tubercidin and other adenosine analogs on Schistosoma mansoni schistosomules.
    Dovey HF; McKerrow JH; Wang CC
    Mol Biochem Parasitol; 1985 Aug; 16(2):185-98. PubMed ID: 3929087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 2'-deoxycoformycin infusion on mouse phosphoribosyl pyrophosphate synthetase.
    Yip LC; Tedde A; Balis ME
    Biochem Pharmacol; 1980 Oct; 29(20):2888-90. PubMed ID: 6254541
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of the activity of 2'-deoxycoformycin and erythro-9-(2-hydroxy-3-nonyl)adenine in vivo.
    Plunkett W; Alexander L; Chubb S; Loo TL
    Biochem Pharmacol; 1979; 28(2):201-6. PubMed ID: 426835
    [No Abstract]   [Full Text] [Related]  

  • 20. N-Methylformycins. Reactivity with adenosine deaminase, incorporation into intracellular nucleotides of human erythrocytes and L 1210 cells and cytotoxicity to L 1210 cells.
    Crabtree GW; Agarwal RP; Parks RE; Lewis AF; Wotring LL; Townsend LB
    Biochem Pharmacol; 1979 May; 28(9):1491-500. PubMed ID: 475858
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.